Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
Enliven Therapeutics priced an upsized public offering of 8.93 million shares at $37.50 per share, alongside 1.73 million pre-funded warrants at $37.499. The offering generates approximately $400 million in gross proceeds, with a 30-day over-allotment option for an additional 1.6 million shares.
Key figures
- Deal Value Usd
- 400000000
- Offering Price
- 37.5
- Shares Offered
- 8933334
- Pre funded warrants
- 1733333
- Pre funded warrant price
- 37.499
- Overallotment option shares
- 1600000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.